糖尿病、高血压和吸烟不影响慢性近端静脉流出道梗阻的髂股静脉支架置入术结局
该回顾性注册研究分析了2011年8月至2021年6月接受髂股静脉支架置入术的708例慢性静脉功能不全患者,评估糖尿病、高血压和吸烟对再干预及症状改善的影响。结果显示三种合并症患病率分别为23.0%、51.1%和22.2%,但与再干预无显著关联,术后VCSS改善在各随访点均无差异。
要点
- 糖尿病、高血压和吸烟在慢性静脉功能不全患者中患病率分别为23.0%、51.1%和22.2%。
- 有高血压和吸烟者CEAP评分高于无相应合并症者,糖尿病者CEAP评分差异未达统计学显著。
- 三种合并症与主要再干预风险及无再干预生存均无显著关联。
核心结论
- 糖尿病、高血压和吸烟在慢性静脉功能不全患者中常见,但与外周动脉疾病不同,对髂股静脉支架置入术后长期结局或再干预几乎没有影响。
研究设计与样本
- 回顾性分析2011年8月至2021年6月接受髂股静脉支架置入术的708例患者的注册数据,使用VCSS和CEAP分类量化症状,记录主要和次要再干预,采用 logistic 回归计算未调整和调整后的再干预比值比,用 log-rank 检验评估无再干预生存差异。
主要发现
- 高血压患病率为51.1%(N=362),糖尿病为23.0%(N=163),吸烟为22.2%(N=157)。
- 糖尿病患者CEAP评分为3.6 vs 无糖尿病者3.4(P=0.062),高血压患者为3.6 vs 无高血压者3.3(P<0.001),吸烟者为3.7 vs 不吸烟者3.4(P=0.003)。
- VCSS复合评分改善在术后(糖尿病P=0.513;高血压P=0.053;吸烟P=0.608)、1年随访(糖尿病P=0.666;高血压P=0.681;吸烟P=0.745)和5年随访(糖尿病P=0.525;高血压P=0.953;吸烟P=0.146)均无差异。
- 糖尿病(P=0.454)、吸烟(P=0.355)和高血压(P=0.727)与主要再干预比值增加无关。
- log-rank检验显示有无糖尿病(P=0.79)、高血压(P=0.14)和吸烟(P=0.80)者主要或次要再手术的无再干预生存无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes, hypertension, and smoking are well-recognized risk factors for peripheral artery disease (PAD), but little is known of their impact on chronic venous insufficiency (CVI). This study evaluates these factors in patients undergoing iliac vein stenting (IVS) for CVI. METHODS: A registry of 708 patients who underwent IVS from August 2011 to June 2021 was retrospectively analyzed. Symptoms were quantified using venous clinical severity score (VCSS) and CEAP classification. Both major and minor reinterventions were recorded. Logistic regression models were used to determine the unadjusted and adjusted odds ratio of any reintervention. Log-rank test was used to assess differences in reintervention-free survival. RESULTS: The prevalence of hypertension was 51.1% (N = 362), diabetes was 23.0% (N = 163), and smoking was 22.2% (N = 157). Patients with diabetes (3.6 vs. 3.4; P = 0.062), hypertension (3.6 vs. 3.3; P < 0.001), and smoking (3.7 vs. 3.4; P = 0.003) had higher CEAP scores than those without these comorbidities. Improvement in VCSS composite scores showed no differences postoperatively (diabetes: P = 0.513; hypertension: P = 0.053; smoking: P = 0.608), at 1-year follow-up (diabetes: P = 0.666; hypertension: P = 0.681; smoking: P = 0.745), or at 5-year follow-up (diabetes: P = 0.525; hypertension: P = 0.953; smoking: P = 0.146). Diabetes (P = 0.454), smoking (P = 0.355), and hypertension (P = 0.727) were not associated with increased odds of major reintervention. Log-rank test similarly showed no differences in reintervention-free survival for major or minor reoperations between those with and without diabetes (P = 0.79), hypertension (P = 0.14), and smoking (P = 0.80). CONCLUSIONS: Diabetes, hypertension, and smoking were prevalent among CVI patients, but unlike in PAD patients, they had little to no impact on long-term outcomes or reinterventions after IVS.
引用
- Kang Y, Bai H, Storch JB, et al. Diabetes, Hypertension, and Smoking Do Not Affect Outcomes of Iliofemoral Vein Stenting for Chronic Proximal Venous Outflow Obstruction. Ann Vasc Surg. 2023. PMID: 37944896. doi:10.1016/j.avsg.2023.09.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。